Search
for

    Sort by

    Research 811–840 of 1000+

    1. Efficacy and safety of deuruxolitinib, an oral selective Janus kinase 1/2 inhibitor, in adults with alopecia areata: Results from the THRIVE-AA2 Phase 3, randomized, double-blind, controlled trial Journal of the American Academy of Dermatology · 2025 · 2 citations
    2. Alopecia areata: a comprehensive review of clinical, immunologic, and genetic perspectives Discover Immunity. · 2025 · 2 citations
    3. Evaluation of the efficacy and treatment-emergent adverse events of deuruxolitinib for moderate to severe alopecia areata: a dose-ranging meta-analysis of 1,372 randomized patients Frontiers in Medicine · 2025 · 2 citations
    4. Applications of Antioxidant Nanoparticles in Immune-Mediated Inflammatory Diseases Antioxidants · 2025 · 2 citations
    5. Efficacy of Upadacitinib in Treating Alopecia Areata, Atopic Dermatitis, and Th1 Comorbidities in Pediatric Patients: A Comprehensive Case Series and Literature Review Journal of Clinical Medicine · 2025 · 2 citations
    6. Serum-Based Assessment of Alopecia Areata Response to Treatment Using ATR-FTIR Spectroscopy Diagnostics · 2025 · 2 citations
    7. Clinical Features and Treatment Options of Vogt-Koyanagi-Harada Disease IntechOpen eBooks · 2025 · 2 citations
    8. Identifying barriers and disparities in the healthcare of patients with alopecia areata: a mixed-methods analysis using claims data and qualitative interview data BMJ Open · 2025 · 2 citations
    9. Cytokine-Targeting Biologic Therapies for Alopecia Areata: A Comprehensive Review of Mechanism of Action, Clinical Efficacy, and Adverse Events Biologics · 2025 · 2 citations
    10. A retrospective clinical and laboratory analysis including vitamin D and antinuclear antibodies in central centrifugal cicatricial alopecia and nonscarring alopecia in African Americans Journal of the American Academy of Dermatology · 2024 · 2 citations
    11. 51840 Efficacy of the Oral JAK1/JAK2 Inhibitor Deuruxolitinib in Adult Patients with Moderate to Severe Alopecia Areata: Pooled Results from the Multinational Double-Blind, Placebo-Controlled THRIVE-AA1 and THRIVE-AA2 Phase 3 Trials Journal of the American Academy of Dermatology · 2024 · 2 citations
    12. Alopecia Areata of the Nails: Diagnosis and Management Journal of Clinical Medicine · 2024 · 2 citations
    13. Drug Survival and Long-term Outcome of Tofacitinib in Patients with Alopecia Areata: A Retrospective Study Acta dermato-venereologica · 2023 · 2 citations
    14. Co-expression of PADI isoforms during progenitor differentiation enables functional diversity Philosophical Transactions of the Royal Society B Biological Sciences · 2023 · 2 citations
    15. Effects of Allium hookeri Extracts on Hair-Inductive and Anti-Oxidative Properties in Human Dermal Papilla Cells Plants · 2023 · 2 citations
    16. Effects of natural products on skin inflammation caused by abnormal hormones secreted by the adrenal gland Frontiers in Pharmacology · 2023 · 2 citations
    17. AIRE Deficiency Leads to the Development of Alopecia Areata‒Like Lesions in Mice 2022 · 2 citations
    18. Real‐world experience and long‐term evaluation of tofacitinib in refractory alopecia areata: A prospective, open‐label, single‐center study in Asian Arab population Dermatologic Therapy · 2022 · 2 citations
    19. Regulation and dysregulation of hair regeneration: aiming for clinical application Cell Regeneration · 2022 · 2 citations
    20. Alopecia areata – Aktuelles Verständnis und Management JDDG Journal der Deutschen Dermatologischen Gesellschaft · 2022 · 2 citations
    21. Tofacitinib Treatment in Patients With Active COVID-19 Infection Curēus · 2021 · 2 citations
    22. Alopecia Areata: Clinical Treatment 2019 · 2 citations
    23. Pili trianguli et canaliculi as a phenotypic subtype in patients with central centrifugal cicatricial alopecia: A scanning electron microscopy study Journal of the American Academy of Dermatology · 2020 · 2 citations
    24. Progressive alopecia areata during TNF-α inhibition with intralesional corticosteroid failure and subsequent improvement following JAK1 inhibition Journal of Dermatological Treatment · 2026 · 1 citations
    25. Ritlecitinib for Severe Alopecia Areata: A 24-Week, Multicentre, Real-World Study American Journal of Clinical Dermatology · 2026 · 1 citations
    26. Phytochemicals for Hair Health Targeting Growth Signaling Molecules in Hair Follicular Stem Cells: A New Strategy for Hair Growth Journal of Microbiology and Biotechnology · 2025 · 1 citations
    27. Improvement in Patient‐Reported Emotional Symptoms and Activity Limitations due to Hair Loss in Patients With Alopecia Areata Treated With Ritlecitinib: Additional Analyses From ALLEGRO ‐2b/3 International Journal of Dermatology · 2025 · 1 citations
    28. Alopecia Areata Associated with Dupilumab: National Database Study Diagnostics · 2025 · 1 citations
    29. The Diverse Experiences and Challenges of Individuals With Alopecia Areata: Survey Results From Finland Journal of Patient Experience · 2025 · 1 citations
    30. Macrophage-Centric Immunometabolic Crosstalk in Alopecia Areata Pathogenesis: Mechanisms and Therapeutic Implications Clinical Reviews in Allergy & Immunology · 2025 · 1 citations